Institutional members access full text with Ovid®

Share this article on:

Cost-effectiveness of Cervical Cancer Prevention

M. ESSELEN, KATHARINE MD, MBA; FELDMAN, SARAH MD, MPH

Clinical Obstetrics & Gynecology: March 2013 - Volume 56 - Issue 1 - p 55–64
doi: 10.1097/GRF.0b013e3182823797
Screening Tests for Cervical Cancer

Cost-effectiveness analyses are an important tool for the evaluation and modification of many health care services. Given the variety of screening tests and treatments available for cervical cancer screening and prevention, the costs associated with these options and with their alternatives, and the differences in resources and settings in which these tests are applied worldwide, cost-effectiveness analyses evaluation can be very useful to help determine best practices.

Brigham and Women’s Hospital, Boston, Massachusetts

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, http://www.clinicalobgyn.com.

The authors declare that they have nothing to disclose.

Correspondence: Sarah Feldman, MD, MPH, Brigham and Women’s Hospital, Boston, MA. E-mail: sfedman@partners.org

© 2013 Lippincott Williams & Wilkins, Inc.